The importance of the interaction between doctor and patient with inflammatory bowel disease by Manuel Barreiro-de-Acosta

Get full text

Clinical applications of NOD2/CARD15 mutations in Crohn´s disease by Manuel Barreiro-de Acosta, Amado S Peña

Get full text

Pharmaceutical costs for inflammatory bowel disease units: an issue for department heads? The GESTIONAEII survey by Federico Argüelles-Arias, Manuel Barreiro-de-Acosta, Joaquín Hinojosa

Get full text

Efficacy of adalimumab for the treatment of extraintestinal manifestations of Crohn's disease Eficacia del adalimumab en el tratamiento de las manifestaciones extraintestinales de... by Manuel Barreiro-de-Acosta, Aurelio Lorenzo, J. Enrique Domínguez-Muñoz

Get full text

Down's syndrome and inflammatory bowel disease: is there a real link? by Raquel Souto-Rodríguez, Manuel Barreiro-de-Acosta, J. Enrique Domínguez-Muñoz

Get full text

Disease clearance in ulcerative colitis: Setting the therapeutic goals for future in the treatment of ulcerative colitis by Laura Ramos, Laura Ramos, Jeny Teo-Loy, Manuel Barreiro-de Acosta

Get full text

Avascular necrosis of the knees and ulcerative colitis Necrosis avascular de rodillas y colitis ulcerosa by Eva Pérez-Pampín, Joaquín Campos-Franco, Laura Losada-Ares, Manuel Barreiro-de-Acosta

Get full text

New contributions to consensus on biosimilars by Federico Argüelles-Arias, Manuel Barreiro-de-Acosta, Fernando Carballo, Joaquín Hinojosa, Teresa Tejerina

Get full text

Author's answer: biosimilar therapy for inflammatory bowel disease by Federico Argüelles-Arias, Manuel Barreiro-de-Acosta, Fernando Carballo, Joaquín Hinojosa, Teresa Tejerina

Get full text

Managing ulcerative colitis after surgery by Cristina Calvino-Suarez, Rocío Ferreiro-Iglesias, Iria Baston Rey, Manuel Barreiro-de Acosta

Get full text

How is inflammatory bowel disease managed in Spanish gastroenterology departments?: the results of the GESTIONA-EII survey by Manuel Barreiro-de-Acosta, Federico Argüelles-Arias, Joaquín Hinojosa, Javier Júdez-Gutiérrez, José María Tenías

Get full text

Management of Non-response and Loss of Response to Anti-tumor Necrosis Factor Therapy in Inflammatory Bowel Disease by Jan Marsal, Jan Marsal, Manuel Barreiro-de Acosta, Irina Blumenstein, Maria Cappello, Thomas Bazin, Shaji Sebastian

Get full text

Efficacy of intravenous iron in treating iron deficiency anaemia in patients with inflammatory bowel disease: Are there predictors of response? by Rocío Ferreiro Iglesias, Manuel Barreiro-de Acosta, Susana Seijo-Ríos, Aurelio Lorenzo, J. Enrique Domínguez-Muñoz

Get full text

Recent Advances and Potential Multi-Omics Approaches in the Early Phases of Inflammatory Bowel Disease by Iago Rodríguez-Lago, Jonathan Blackwell, Beatriz Mateos, Urko M. Marigorta, Manuel Barreiro-de Acosta, Richard Pollok

Get full text

Epidemiology and hospital resources use in the treatment of ulcerative colitis at gastroenterology units in Spain (EPICURE study) by Ignacio Marín-Jiménez, Cristina Saro, Verónica Díaz, Manuel Barreiro-de Acosta, María Gómez-García, Ana Gutiérrez Casbas

Get full text

Fear of COVID-19 Among Patients with Inflammatory Bowel Disease as Compared to Patients with Other Gastrointestinal Conditions by Bobby Lo, Manuel Barreiro-de Acosta, Charles N. Bernstein, Johan Burisch, Nuno Ferreira, Richard B. Gearry, Antonina Mikocka-Walus, Anna Mokrowiecka, Inês A. Trindade, Simon R. Knowles

Get full text

Clinical status, quality of life, and work productivity in Crohn's disease patients after one year of treatment with adalimumab by Cristina Saro, Daniel Ceballos, Fernando Muñoz, Cristóbal de-la-Coba, María Dolores Aguilar, Pablo Lázaro, Valle García-Sánchez, Mariola Hernández, Jesús Barrio, Ruth de-Francisco, Luis I. Fernández, Manuel Barreiro-de-Acosta

Get full text

Enhancing Therapeutic Drug Monitoring in Inflammatory Bowel Disease: A Comparative Analysis of Rapid Point-of-Care Infliximab, Adalimumab and Anti-Drug Antibodies’ Determination ag... by Francisco José Toja-Camba, Laura García-Quintanilla, Lorena Rodríguez-Martinez, Julia Tomine, Francisco Cajade-Pascual, Carolina Feitosa, Irene Zarra-Ferro, Manuel Barreiro-De-Acosta, Jaime González-López, Cristina Mondelo-García, Anxo Fernández-Ferreiro

Get full text

Preferences and satisfaction of IBD patients after switching from adalimumab 40 mg weekly to 80 mg every other week given as a single injection: the ADASCAL study by Carlos Taxonera, María Pilar Martínez-Montiel, Manuel Barreiro-de-Acosta, Isabel Vera, Rufo Lorente, Pablo Vega, María Teresa Diz-Lois, Ana María Fuentes Coronel, José Lázaro Pérez Calle, Begoña Casis, Rocío Ferreiro-Iglesias, Marta Calvo, David Olivares, Cristina Alba

Get full text

EpidemIBD: rationale and design of a large-scale epidemiological study of inflammatory bowel disease in Spain by María Chaparro, Manuel Barreiro-de Acosta, José Manuel Benítez, José Luis Cabriada, María José Casanova, Daniel Ceballos, María Esteve, Hipólito Fernández, Daniel Ginard, Fernando Gomollón, Rufo Lorente, Pilar Nos, Sabino Riestra, Montserrat Rivero, Pilar Robledo, Cristina Rodríguez, Beatriz Sicilia, Emilio Torrella, Ana Garre, Esther García-Esquinas, Fernando Rodríguez-Artalejo, Javier P. Gisbert

Get full text